OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Gunderson on the Use of PARP Inhibitors in All-Comers With Ovarian Cancer

April 9th 2020

Camille C. Gunderson, MD, assistant professor of gynecologic oncology, Stephenson Cancer Center, discusses the use of PARP inhibitors in all-comers with ovarian cancer.

Dr. Gupta Shares Updates From the Frontlines of the Battle Against COVID-19

April 9th 2020

Shilpa Gupta, MD, shares updates from the frontlines and discusses how she is handling the COVID-19 pandemic.

Dr. Hamilton on Using pCR to Classify Risk in HER2+ Breast Cancer

April 9th 2020

Erika P. Hamilton, MD, director of the Breast Cancer and Gynecologic Research Program and principal investigator at Sarah Cannon Research Institute, discusses the use of pathologic complete response (pCR) as a way to classify risk status in HER2-positive breast cancer.

Dr. Villa on the Use of BR as Induction Therapy in MCL

April 9th 2020

Diego Villa, MD, MPH, clinical associate professor, Division of Medical Oncology, Department of Medicine, The University of British Columbia, discusses the use of bendamustine and rituximab (Rituxan) as induction therapy in mantle cell lymphoma (MCL).

Dr. Comerci on the Use of Laparoscopy in Ovarian Cancer

April 9th 2020

John T. Comerci, MD, associate professor, University of Pittsburgh School of Medicine, and director of Gynecologic Oncology, University of Pittsburgh Medical Center Passavant Hospital, discusses the use of laparoscopy in ovarian cancer.

Dr. Antonarakis on Trial Examining Sipuleucel-T Plus Radium-223 in Bone-Metastatic CRPC

April 9th 2020

Emmanuel S. Antonarakis, MBBCh, discusses the design of a randomized phase II study of sipuleucel-T with or without radium-223 dichloride in men with asymptomatic bone-metastatic castrate-resistant prostate cancer.

Dr. Agarwal on PFS2 Data From the TITAN Trial in mCSPC

April 9th 2020

Neeraj Agarwal, MD, discusses data from a posthoc analysis of the phase III TITAN trial in patients with metastatic castration-sensitive prostate cancer.

Dr. McKay on the Utility of Radium-223 in the Treatment of mCRPC

April 9th 2020

Rana R. McKay, MD, discusses the utility of radium-223 in metastatic castration-resistant prostate cancer.

Dr. Snyder on Tools to Improve Use of Allogeneic Stem Cell Transplant in Myelofibrosis

April 8th 2020

David S. Snyder, MD, discusses tools to improve the use of allogeneic stem cell transplant in myelofibrosis.

Dr. O'Malley on Research With Immunotherapy in Ovarian Cancer

April 8th 2020

David O’Malley, MD, discusses the current state of immunotherapy in ovarian cancer.

Dr. Mato on the Efficacy of Fixed-Duration Venetoclax-Based Combo in CLL

April 8th 2020

Anthony R. Mato, MD, MSCE, discusses the phase III CLL14 trial, which evaluated the efficacy of fixed-duration treatment with venetoclax plus obinutuzumab in patients with chronic lymphocytic leukemia.

Dr. Jain on High-Risk Mutations in Myelofibrosis

April 8th 2020

Tania Jain, MBBS, sheds light on the mutations that confer worse prognosis in myelofibrosis.

Dr. Saint Fleur-Lominy on Remaining Challenges in Myelofibrosis

April 8th 2020

Shella Saint Fleur-Lominy, MD, PhD, discusses remaining challenges in myelofibrosis.

Dr. Sapisochin on the Benefits of Living Donor Transplant in HCC

April 8th 2020

Gonzalo Sapisochin, MD, discusses the benefits of living donor liver transplantation in hepatocellular carcinoma.

Dr. Mesa on Challenges in Myelofibrosis Treatment

April 8th 2020

Ruben Mesa, MD, discusses remaining challenges in treating myelofibrosis.

Dr. Boisen on Scoring System for Optimal Debulking in Ovarian Cancer

April 8th 2020

Michelle M. Boisen, MD, discusses the scoring system for optimal debulking in ovarian cancer.

Dr. Goy on the Progression of MCL Treatment

April 8th 2020

Andre Goy, MD, MS, discusses the paradigm shift in the treatment of patients with mantle cell lymphoma that has occurred over the past decade.

Dr. Accordino on Data From the PEARL Trial in HR+/HER2- Metastatic Breast Cancer

April 8th 2020

Melissa K. Accordino, MD, MS, discusses the findings of the PEARL trial in hormone receptor-positive, HER2-negative metastatic breast cancer.

Dr. Awan on Future of Combo Regimens in CLL Treatment Paradigm

April 8th 2020

Farrukh Awan, MD, discusses questions regarding combination therapies in chronic lymphocytic leukemia.

Dr. Cosgrove on the Utilization of PARP Inhibition in Ovarian Cancer

April 8th 2020

Casey M. Cosgrove, MD, discusses the utilization of PARP inhibition in ovarian cancer.